This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Nir KOSSOVSKY, MD
New York Hospital—Cornell Medical Center New York

Ram Kossowsky, PhD
Applied Research Laboratory Pennsylvania State University University Park

Manuel Dujovny, MD
Henry Ford Hospital Detroit

JAMA. 1985;254(23):3307.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Recently, two separate articles on the artificial heart program appeared simultaneously in THE JOURNAL.^1,2 Both articles failed to mention important medical details on three biomedical device issues: medical device failures, thrombogenicity of silicone, and infections with percutaneous implants. With literally millions of medical devices in use, it is important for today's physician to understand the nature of the body's reaction to devices as well as the devices' reaction to long-term implantation in the body.

First, the fracture of the weld of Barney Clark's Björk-Shiley heart valve on the 13th postoperative day is described as being a manifestation of Murphy's Law.² This is incorrect. The Björk-Shiley 60° convexoconcave valves have a fundamental flaw in the weld and, as of Sept 25, 1984, 107 cases of valve failure due to strut fracture have been reported; two thirds of which were estimated by Shiley to be fatal.³ . . . [Full Text PDF of this Article]

Footnotes
Edited by Drummond Rennie, MD, Senior Contributing Editor; Sharon Iverson, Assistant Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?